Sign inJoin waitlistJoin the waitlist

KS

Kurt Schalper

Director, Translational Immuno-Oncology Laboratory · Yale-New Haven Hospital

Credentials: · · ·

History

Translational Immuno-oncology Laboratory · Yale-New Haven Hospital
Present
Yale-New Haven Hospital
Present

Pathology-Anatomic and Clinical
2003–2007
San Sebastian University
1999–2003

Research

PD-1 Blockade in Mismatch Repair-Deficient, Locally Advanced Rectal Cancer
New England Journal of Medicine · 2022 · 1,296 citations
Molecular Determinants of Response to Anti-Programmed Cell Death (PD)-1 and Anti-Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non-Small-Cell Lung Cancer Profiled…
Journal of Clinical Oncology · 2018 · 1,159 citations
Artificial intelligence in digital pathology - new tools for diagnosis and precision oncology
Review · Nature Reviews Clinical Oncology · 2019 · 1,096 citations

DR
David Rimm
59 papers
RH
Roy Herbst
29 papers
Vamsi Velcheti
25 papers
Scott Gettinger
13 papers
Sarah Goldberg
10 papers
Harriet Kluger
9 papers
Brian Henick
8 papers
Jonathan Riess
7 papers
JG
Justin Gainor
7 papers
Lynette Sholl
7 papers
MH
Matthew Hellmann
7 papers
Lajos Pusztai
6 papers

Grants

Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
National Cancer Institute · P50
Project lead · $1.8M · Yale University
2025–2030
Biological and Clinical Significance of Spatial Immune Heterogenenity in Non-Small Cell Lung Cancer
National Cancer Institute · R21
Contact PI · $478.5K · Yale University
2025–2027
Multiplexed Spatially Resolved Tissue Biomarkers for Optimal Use of PD-1 Axis Blockers and PARP Inhibitors in Cancer.
National Cancer Institute · UH2
Contact PI · $461.4K · Yale University
2025–2027
Quantitative and Spatially-Resolved Analysis of the Tumor Immune Contexture for Optimal Diagnosis and Treatment of Lung Cancer
National Cancer Institute · R37
Contact PI · $2.6M · Yale University
2020–2027